Director, Global Value Evidence Strategy, Nephrology – Immunology

This is a fully remote position, open to applicants in United States.

📋 Description

• Direct the global value evidence strategy for designated nephrology/immunology assets.

• Offer strategic insights for integrated evidence plans.

• Oversee evidence generation that supports value demonstration, market access, reimbursement, and patient access goals.

• Chair the Value Evidence Sub-Committee for applicable products and indications on a global scale.

• Manage health technology and value evidence contributions to clinical development initiatives.

• Participate in product development and internal/alliance governance committees.

• Act as the Value Evidence lead for the creation and upkeep of Integrated Evidence Plans.

• Formulate global value evidence strategies that address the evidence needs of payers, providers, patients, and policymakers.

• Evaluate health technology assessment requirements and monitor methodological necessities.

• Produce economic models, real-world evidence, evidence synthesis, meta-analyses, statistical analysis plans, global value dossiers, and AMCP-format dossiers.

• Coordinate and deliver scientific support for non-US HTA submissions in collaboration with subsidiaries.

• Lead corporate responses to US HTA evaluations, including ICER.

• Generate and develop post-approval real-world evidence alongside external researchers and experts.

• Create publication and communication strategies, presenting and publishing value evidence at conferences and in peer-reviewed journals.

⛳️ Requirements

• A minimum of 6 years of pertinent pharmaceutical company or payer experience for PhD/MD/PharmD holders, or 12 years for Master’s degree holders.

• Background in access, outcomes research, health economics, observational studies, health technology assessment, or a closely related field.

• Experience in late-stage drug development and product launch.

• Knowledge of evidence generation specific to rare diseases.

• A PhD or Master’s degree in health economics, outcomes research, epidemiology, health services research, health policy, pharmaceutical administration, or a relevant discipline, or an MD or PharmD.

• Capability to lead global value evidence strategy and evidence-generation initiatives.

• Familiarity with the evidence needs of payers, providers, patients, and policymakers.

• Proficiency in economic models, real-world evidence, evidence synthesis, meta-analysis, HTA statistical analysis plans, value dossiers, and AMCP-format dossiers.

• Experience in supporting HTA submissions and addressing HTA evaluations.

• Ability to formulate publication and communication plans and disseminate research through conferences and peer-reviewed journals.

🏝️ Benefits

• Incentive opportunities available.

• Comprehensive medical insurance coverage.

• Dental insurance coverage.

• Vision insurance coverage.

• Prescription drug coverage.

• Basic life insurance provided by the company.

• Accidental death and dismemberment insurance.

• Short-term disability insurance.

• Long-term disability insurance.

• Tuition reimbursement program.

• Assistance with student loan repayment.

• Generous 401(k) matching program.

• Flexible time off policy.

• Paid holidays.

• Paid leave programs.

• Additional benefits provided by the company.